Parkinson's Disease Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H2, 2013" provides data on the Parkinson’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Parkinson’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Parkinson’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Parkinson's Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Parkinson's Disease 23
Subjects Recruited Over a Period of Time 32
Prominent Sponsors 33
Top Companies Participating in Parkinson's Disease Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
C. H. Boehringer Sohn AG and Co. KG 37
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 37
UCB S.A. 41
Clinical Trial Overview of UCB S.A. 41
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
Teva Pharmaceutical Industries Limited 48
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 48
AbbVie Inc. 50
Clinical Trial Overview of AbbVie Inc. 50
GlaxoSmithKline plc 52
Clinical Trial Overview of GlaxoSmithKline plc 52
H. Lundbeck A/S 54
Clinical Trial Overview of H. Lundbeck A/S 54
Kirin Holdings Company, Limited 56
Clinical Trial Overview of Kirin Holdings Company, Limited 56
Eisai Co., Ltd. 58
Clinical Trial Overview of Eisai Co., Ltd. 58
Bial - Portela and Ca, S.A. 60
Clinical Trial Overview of Bial - Portela and Ca, S.A. 60
Clinical Trial Overview of Top Institutes / Government 61
National Institute of Neurological Disorders and Stroke 61
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 61
U.S. Department of Veterans Affairs 63
Clinical Trial Overview of U.S. Department of Veterans Affairs 63
Oregon Health and Science University 64
Clinical Trial Overview of Oregon Health and Science University 64
Institute for Neurodegenerative Disorders 65
Clinical Trial Overview of Institute for Neurodegenerative Disorders 65
Radboud University 67
Clinical Trial Overview of Radboud University 67
Washington University School of Medicine 68
Clinical Trial Overview of Washington University School of Medicine 68
Tel-Aviv Sourasky Medical Center 69
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 69
UNIVERSITY HOSPITAL, CLERMONT-FERRAND 70
Clinical Trial Overview of UNIVERSITY HOSPITAL, CLERMONT-FERRAND 70
University of Rochester 71
Clinical Trial Overview of University of Rochester 71
University Hospital, Toulouse 72
Clinical Trial Overview of University Hospital, Toulouse 72
Five Key Clinical Profiles 73
Appendix 148
Abbreviations 148
Definitions 148
Research Methodology 149
Secondary Research 149
About GlobalData 150
Contact Us 150
Disclaimer 150
Source 151



List of Tables

Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Parkinson's Disease Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Parkinson's Disease Therapeutics Clinical Trials, G7 Countries, 2013* 16
Parkinson's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Parkinson's Disease Therapeutics Clinical Trials, E7 Countries, 2013* 18
Parkinson's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Parkinson's Disease Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Parkinson's Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Parkinson's Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 32
Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Parkinson's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2013* 37
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2013* 41
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 45
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 48
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013* 50
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 52
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 54
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2013* 56
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2013* 58
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bial - Portela and Ca, S.A., 2013* 60
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2013* 61
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 63
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 64
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute for Neurodegenerative Disorders, 2013* 65
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 67
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 68
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2013* 69
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UNIVERSITY HOSPITAL, CLERMONT-FERRAND, 2013* 70
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 71
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2013* 72



List of Figures

Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Parkinson's Disease Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Parkinson's Disease Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Parkinson's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Parkinson's Disease Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Parkinson's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 32
Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Parkinson's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
GlobalData Methodology 149

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Proteomics Markets for Research and IVD Applications

Proteomics Markets for Research and IVD Applications

  • $ 4 200
  • Industry report
  • September 2014
  • by Kalorama Information

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1686 biological ...

Biologicals in Oncology: Drug Pathway Analyzer 2014

Biologicals in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1421 biological drugs known to affect more than 266 specific intracellular signaling pathways for the treatment ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.